Clinical Trials
5 trialsNCT03717298 2023-03-28
Evaluation of Ocoxin-ViusidĀ® in Advanced Pancreatic Adenocarcinoma
Catalysis SL
Phase 2 Completed
NCT03562897 2022-07-06
Evaluation of Ocoxin-ViusidĀ® in Advanced or Metastatic Ovarian Epithelial Cancer
Catalysis SL
Phase 2 Completed
NCT00896454 2018-10-17
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Amgen
Phase 2 Completed
NCT00050414 2013-01-10
A Study of Trabectedin in Patients With Advanced Ovarian Cancer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 2 Completed
NCT00071058 2012-09-18
Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed